Additional qPCR analysis of tumor cells from the mouse bone marrow revealed a significant increase in relative CD38 expression in the panobinostat treatment groups compared to αCD38 antibody alone, highlighting the impact of panobinostat on enhancing CD38 gene expression in vivo (Supplementary Fig. 4C). The gene discussed is CD38; the disease is neoplasm.